<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We previously detected an association between a region of the <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor-alpha (ESR1) gene and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in an African-American case-control study; thus, we investigated this region for associations with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and its component traits in African-American families from the <z:hpo ids='HP_0000855'>Insulin Resistance</z:hpo> <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> Family Study </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 17 single nucleotide polymorphisms (SNPs) from a contiguous 41-kb intron 1-intron 2 region of the ESR1 gene were genotyped in 548 individuals from 42 African-American pedigrees </plain></SENT>
<SENT sid="2" pm="."><plain>Generalized estimating equations were computed using a sandwich estimator of the variance and exchangeable correlation to account for familial correlation </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Significant associations were detected between ESR1 SNPs and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (P = 0.005 to P = 0.029), type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (P = 0.001), insulin sensitivity (P = 0.0005 to P = 0.023), fasting insulin (P = 0.022 to P = 0.033), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P = 0.021), <z:chebi fb="15" ids="39026">LDL</z:chebi> (P = 0.016 to P = 0.034), cholesterol (P = 0.046), BMI (P = 0.016 to P = 0.035), waist circumference (P = 0.012 to P = 0.023), and subcutaneous adipose tissue area (P = 0.016) </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: It appears likely that ESR1 contributes to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk via pleiotropic effects, leading to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, a poor <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>